Clinical trial
Feasibility of Isolating P16 Expression
NCT03160768 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Isolating P16 Expression
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 25, 2017
- Completion date
- May 2, 2019
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
childhood cancer